| scholarly article | Q13442814 |
| P50 | author | Safaa I Tayel | Q54257673 |
| P2093 | author name string | Waleed A Ibrahim | |
| Heba F Khader | |||
| Nesreen G El-Helbawy | |||
| P2860 | cites work | The insertion/deletion variation in the alpha2B-adrenoceptor does not seem to modify the risk for acute myocardial infarction, but may modify the risk for hypertension in sib-pairs from families with type 2 diabetes | Q24802084 |
| Expression of alpha 2- and beta-adrenoceptor subtypes in human islets of Langerhans | Q27867690 | ||
| Global burden of hypertension: analysis of worldwide data | Q28302545 | ||
| Heart disease and stroke statistics--2011 update: a report from the American Heart Association | Q29547236 | ||
| An insertion/deletion polymorphism in the α2b-adrenergic receptor gene is a novel genetic risk factor for acute coronary events | Q57303695 | ||
| Identification of a polymorphic glutamic acid stretch in the α2b-adrenergic receptor and lack of linkage with essential hypertension | Q57318987 | ||
| Effect of a three-amino acid deletion in the α2B-adrenergic receptor gene on long-term body weight change in Finnish non-diabetic and type 2 diabetic subjects | Q61713503 | ||
| A Simple Procedure for Human Lymphocyte Isolation from Peripheral Blood | Q70496102 | ||
| Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus | Q77678908 | ||
| An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with peripheral neuropathy in patients with type 2 diabetes mellitus | Q80363135 | ||
| Hypertension awareness, treatment, and control--continued disparities in adults: United States, 2005-2006 | Q83710687 | ||
| Selected major risk factors and global and regional burden of disease | Q29614888 | ||
| The vasodilatory actions of insulin on resistance and terminal arterioles and their impact on muscle glucose uptake | Q30312289 | ||
| Identification of a three-amino acid deletion in the alpha2B-adrenergic receptor that is associated with reduced basal metabolic rate in obese subjects | Q33867916 | ||
| Genome-wide scan of predisposing loci for increased diastolic blood pressure in Finnish siblings | Q34084406 | ||
| Linkage of essential hypertension to chromosome 18q. | Q34132270 | ||
| Functional variant in the (alpha)2B adrenoceptor gene, a positional candidate on chromosome 2, associates with hypertension | Q34292748 | ||
| Association between a deletion/insertion polymorphism in the alpha2B-adrenergic receptor gene and insulin secretion and Type 2 diabetes. The Finnish Diabetes Prevention Study | Q34340929 | ||
| Impaired desensitization of a human polymorphic α2B-adrenergic receptor variant enhances its sympatho-inhibitory activity in chromaffin cells | Q34586312 | ||
| Physiological significance of alpha(2)-adrenergic receptor subtype diversity: one receptor is not enough | Q34744859 | ||
| Beta-cell dysfunction and insulin resistance in type 2 diabetes: role of metabolic and genetic abnormalities | Q34996991 | ||
| Variants of ADRA2A are associated with fasting glucose, blood pressure, body mass index and type 2 diabetes risk: meta-analysis of four prospective studies | Q35031678 | ||
| Adrenergic receptor knockout mice: distinct functions of 9 receptor subtypes | Q35632073 | ||
| Noradrenergic pain modulation | Q36618448 | ||
| Association of insertion/deletion polymorphism of alpha-adrenoceptor gene in essential hypertension with or without type 2 diabetes mellitus in Malaysian subjects | Q36938156 | ||
| Adrenergic Signaling Polymorphisms and Their Impact on Cardiovascular Disease | Q37776088 | ||
| International Union of Pharmacology nomenclature of adrenoceptors | Q40638526 | ||
| Pharmacologic and therapeutic applications of alpha 2-adrenoceptor subtypes | Q40710042 | ||
| Genome-wide linkage analysis of systolic and diastolic blood pressure: the Québec Family Study | Q40743267 | ||
| Alpha 2-adrenergic receptor gene polymorphism and hypertension in blacks | Q41676928 | ||
| Guidelines from the British Hypertension Society: BHS is set to bankrupt NHS | Q42394025 | ||
| An insertion/deletion polymorphism in the alpha2B adrenoceptor gene is associated with age at onset of type 2 diabetes mellitus | Q44163397 | ||
| Alpha(2B)-adrenergic receptor deletion polymorphism associates with autonomic nervous system activity in young healthy Japanese | Q44357235 | ||
| A deletion in the alpha2B-adrenergic receptor gene and autonomic nervous function in central obesity | Q47691630 | ||
| A genome wide scan for early onset primary hypertension in Scandinavians | Q47697202 | ||
| Insertion/insertion genotype of α2B-adrenergic receptor gene polymorphism is associated with silent myocardial ischemia in patients with type 2 diabetes mellitus | Q49093167 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P921 | main subject | type 2 diabetes | Q3025883 |
| P304 | page(s) | 111-118 | |
| P577 | publication date | 2012-12-04 | |
| P1433 | published in | The Application of Clinical Genetics | Q15817525 |
| P1476 | title | Association of deletion allele of insertion/deletion polymorphism in α2B adrenoceptor gene and hypertension with or without type 2 diabetes mellitus | |
| P478 | volume | 5 |
| Q33844872 | Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes |
| Q64103561 | Neurally mediated syncope diagnosis based on adenylate cyclase activity in Japanese patients |
| Q33165592 | Relationship between human evolution and neurally mediated syncope disclosed by the polymorphic sites of the adrenergic receptor gene α2B-AR. |
Search more.